Global Transradial Access Market, By Application (Fluid and Nutrition Administration, Drug Administration, Blood Transfusion, Diagnostics and Testing), Product (Guidewires, Catheters, Sheaths and Sheath Introducers, Accessories), End Users (Hospitals, Ambulatory Centers, Clinics, Community Healthcare, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights Global Transradial Access Market
Data Bridge Market Research analyses that the transradial access market to be grow at a CAGR of 9.3% in the forecast period of 2022-2029 and is likely to reach the USD 2,883.63 million by 2029.
The transradial access procedure, which comprises diagnostic angiography, angioplasty, and percutaneous stenting, is utilized in the identification of coronary artery disease. Sheaths, catheters, guidewires, sheath introducers, and other tiny components are included in the transradial access kit. The transradial access method can discover a blockage in a cardiac artery in a patient who is experiencing pain and suffering from the condition. This method can also help doctors and healthcare providers decide on a treatment plan.
The rise in the prevalence of lifestyle disorders and cardiovascular diseases will act as major driver accelerating the transradial access market’s growth rate. Another significant factor resulting in the expansion of market is the upsurge in the number of geriatric population. Furthermore, surging number of chemotherapy procedures and growing utilization of radial access devices in paediatric patients are the major drivers that will enhance the growth of market. Likewise, rise in the number of patients suffering from obesity and rapid urbanisation will show positive impact on the market’s growth rate. Growing healthcare expenditure, changing lifestyle and rise in the level of disposable incomes in developing and developed countries will influence the growth rate of transradial access market.
Moreover, rise in the preference for interventional procedures using radial artery access and advancement in medical technology will provide beneficial opportunities for the transradial access market growth. Additionally, increasing demand from emerging markets and rising awareness about health will further expand the transradial access market’s growth rate in the future.
On the other hand, high cost associated with the placement and maintenance of vascular access devices will obstruct the market growth. Also, risk associated with radial access devices and product failure and recalls marketing will challenge the transradial access market. However, lack of healthcare professionals and the less awareness will act as restrain and further impede the growth rate of market.
This transradial access market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on transradial access market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Transradial Access Market Scope and Market Size
The transradial access market is segmented on the basis of application, product and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on application, the transradial access market is segmented into fluid and nutrition administration, drug administration, blood transfusion and diagnostics and testing.
- Transradial access market has also been segmented based on the product into guidewires, catheters, sheaths and sheath introducers and accessories.
- On the basis of end users, the transradial access market is segmented into hospitals, ambulatory centers, clinics, community healthcare and others.
Transradial Access Market Country Level Analysis
The transradial access market is segmented on the basis of application, product and end users.
The countries covered in the transradial access market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the transradial access market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the rising prevalence rate of cardiovascular diseases and growing number of conferences and workshops in this region. Additionally, rising number of patients suffering from cancer and growing research and clinical trials for vascular access devices will propel the market’s growth rate in this region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the rising number of cases of cardiovascular diseases and technological advancement in this region.
The country section of the transradial access market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The transradial access market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for transradial access market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the transradial access market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Global Transradial Access Market Share Analysis
The transradial access market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to transradial access market.
Some of the major players operating in the transradial access market are AngioDynamics, Smiths Group plc, Merit Medical Systems, NIPRO, Penumbra, Inc., Cardinal Health, Medtronic, Stryker, BD, Terumo Corporation, Teleflex Incorporated, Smiths Group plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Merit Medical Systems Inc., Amecath, OSCOR Inc., Zimmer Biomet, B. Braun Melsungen AG, Medical Devices Business Services, Inc., and KLS Martin Group, among others.